{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-009336","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2025-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.706348+00:00","generated_at":"2026-05-25T08:26:15.074675+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Enveric Biosciences regains Nasdaq bid price compliance","bullets":["Received notice from Nasdaq on March 4, 2025 that it complied with Listing Rule 5550(a)(2).","Compliance resolves potential delisting risk due to low stock price.","Company's common stock continues trading on Nasdaq under symbol ENVB."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-009336","json":"https://secwatch.observer/filing/0001493152-25-009336.json","markdown":"https://secwatch.observer/filing/0001493152-25-009336.md","text":"https://secwatch.observer/filing/0001493152-25-009336.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315225009336/0001493152-25-009336-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315225009336/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T08:26:15.074675+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}